RÉSUMÉ
The possible roles of spinal histamine receptors in the regulation of the blood glucose level were studied in ICR mice. Mice were intrathecally (i.t.) treated with histamine 1 (H1) receptor agonist (2-pyridylethylamine) or antagonist (cetirizine), histamine 2 (H2) receptor agonist (dimaprit) or antagonist (ranitidine), histamine 3 (H3) receptor agonist (alpha-methylhistamine) or antagonist (carcinine) and histamine 4 (H4) receptor agonist (VUF 8430) or antagonist (JNJ 7777120), and the blood glucose level was measured at 30, 60 and 120 min after i.t. administration. The i.t. injection with alpha-methylhistamine, but not carcinine slightly caused an elevation of the blood glucose level. In addition, histamine H1, H2, and H4 receptor agonists and antagonists did not affect the blood glucose level. In D-glucose-fed model, i.t. pretreatment with cetirizine enhanced the blood glucose level, whereas 2-pyridylethylamine did not affect. The i.t. pretreatment with dimaprit, but not ranitidine, enhanced the blood glucose level in D-glucose-fed model. In addition, alpha-methylhistamine, but not carcinine, slightly but significantly enhanced the blood glucose level D-glucose-fed model. Finally, i.t. pretreatment with JNJ 7777120, but not VUF 8430, slightly but significantly increased the blood glucose level. Although histamine receptors themselves located at the spinal cord do not exert any effect on the regulation of the blood glucose level, our results suggest that the activation of spinal histamine H2 receptors and the blockade of spinal histamine H1 or H3 receptors may play modulatory roles for up-regulation and down-regulation, respectively, of the blood glucose level in D-glucose fed model.
Sujet(s)
Animaux , Souris , Glycémie , Cétirizine , Dimaprit , Régulation négative , Glucose , Histamine , Souris de lignée ICR , Ranitidine , Récepteur histaminergique H2 , Récepteur histaminergique H3 , Récepteurs histaminergiques , Moelle spinale , Régulation positiveRÉSUMÉ
<p><b>OBJECTIVE</b>To observe the influence of betahistine on the expression of histamine H3 receptor in the medial vestibular nucleus (MVN) following unilateral labyrinthectomy (UL).</p><p><b>METHODS</b>Fifty-six healthy guinea pigs were randomly divided into three groups:the sham-operated group (group I), the UL group[group II, and UL+betahistine (BET) group (group III)], BET was intraperitoneally injection at 2.17 mg×kg(-1)×d(-1) for 7 days. The expression of histamine H3 receptor was analyzed by immunohistochemistry at 1 day, 3 days and 7 days after UL.</p><p><b>RESULTS</b>H3 receptors were presented in the MVN and the expression of histamine H3 receptor were increased significantly in the ipsilateral MVN at 1 and 3 days after UL(P < 0.05), the change turned into the normal value at 7 days(P > 0.05). In the UL+BET group, the intensity of histamine H3 receptor was lower than that in the UL at 1 day and 3 days(4.25 ± 0.71, 3.50 ± 0.92 vs 5.75 ± 0.71, 5.50 ± 0.93, P < 0.05). However, the changes turned into the normal values at 3 and 7 days (P > 0.05).</p><p><b>CONCLUSIONS</b>The early stage of the vestibular compensation process may be associated with the change of H3 receptor expression in MVN. In the UL+BET group the histamine H3 receptor recovered quickly.</p>
Sujet(s)
Animaux , Bétahistine , Métabolisme , Oreille interne , Cochons d'Inde , Procédures de chirurgie otologique , Récepteur histaminergique H3 , Métabolisme , Noyaux vestibulaires , Métabolisme , Labyrinthe vestibulaire , Chirurgie généraleRÉSUMÉ
OBJECTIVES: Thioperamide is used as an antagonist to the histamine H3 receptor. During administration of the drug, the trachea may be affected via nasal or oral inhalation. This study was to determine the effects of thioperamide on the trachea of rats in vitro. METHODS: We tested the effectiveness of thioperamide on isolated rat trachea submersed in Kreb's solution in a muscle bath. Changes in tracheal contractility in response to the application of parasympathetic mimetic agents were measured. The following assessments of thioperamide were performed: 1) effect on tracheal smooth muscle resting tension; 2) effect on contraction caused by 10(-6) M methacholine as a parasympathetic mimetic; 3) effect of the drug on electrically-induced tracheal smooth muscle contractions. RESULTS: Thioperamide induced a significant relaxation response at a preparation concentration up to 10(-4) M. The drug also inhibited the electrical field stimulation induced spike contraction. However, thioperamide alone had a minimal effect on the basal tension of the trachea at increasing concentrations. CONCLUSION: The study indicated that high concentrations of thioperamide might actually antagonize cholinergic receptors and block parasympathetic function of the trachea.
Sujet(s)
Animaux , Rats , Asthme , Bains , Contrats , Inspiration , Chlorure de méthacholine , Muscles lisses , Muscles , Pipéridines , Récepteurs cholinergiques , Récepteur histaminergique H3 , Relaxation , TrachéeRÉSUMÉ
<p><b>OBJECTIVE</b>To identify a HEK293 cell line containing stably-transfected H3R gene, and to screen the novel non-imidazole compounds with H3R antagonist activity.</p><p><b>METHODS</b>The expression of rat H3 receptor in cell line was detected by RT-PCR and Western blot. An elevation of intercellular cAMP concentration induced by forskolin was measured as the index for screening compounds with H3R antagonist activity.</p><p><b>RESULTS</b>The H3R-transfected HEK-293 cells stably expressed high level of rat H3 receptor mRNA and protein. Forskolin significantly increased intercellular cAMP concentration in the H3R-transfected HEK-293 cells. H3R agonist (R)-α-methylhistamine inhibited the forskolin-induced production of intercellular cAMP. H3R antagonist thioperamide and newly synthesized non-imidazole compounds XHA23 and XHA25 blocked (R)-α- methylhistamine reversal of forskolin-induced cAMP formation in a concentration-dependent manner, and the IC50 values were 3.62 μmol/L, 0.49 μmol/L, 0.14 μmol/L, respectively.</p><p><b>CONCLUSION</b>The H3R-transfected HEK293 cells stably express high level of rat H3 receptor, and can be used for screening compounds with H3R antagonist activity. The non-imidazole compounds XHA23 and XHA25 may have H3R antagonist activity.</p>
Sujet(s)
Animaux , Humains , Rats , Évaluation préclinique de médicament , Cellules HEK293 , Antihistaminiques des récepteurs H3 , Récepteur histaminergique H3 , Génétique , Métabolisme , TransfectionRÉSUMÉ
OBJECTIVE@#To discuss the treatment of H3R agonist, IMETIT, on the allergic rhinitis(AR) ,and the influence to mRNA of Substance P(SP) and Substance P Receptor (SP-R) in AR model of guinea pigs.@*METHOD@#The severity of AR was assessed by allergic symptoms (sneezing, nasal rubbing and nose blocking). The changes in the nasal mucosa were studied by pathological methods. The expression of SP positive cell was detected by immunohistochemistry, and the expression of SP-R mRNA was detected by reverse transcriptive polymerase chain reaction (RT-PCR).@*RESULT@#Histamine H3R agonists, IMETIT can effectively improve the AR symptoms, sneezing, nasal itching, nasal congestion, reduce the pathological changes in the nasal mucosa, cut down the SP secretion and SP-R mRNA expression.@*CONCLUSION@#Histamine H3R agonist, IMETIT can effectively relieve the symptoms of AR in guinea pigs, which is related to reducing SP secretion and SP-R mRNA expression.
Sujet(s)
Animaux , Femelle , Mâle , Cochons d'Inde , Imidazoles , Utilisations thérapeutiques , Récepteur histaminergique H3 , Récepteur de la neurokinine 1 , Génétique , Métabolisme , Rhinite spasmodique apériodique , Traitement médicamenteux , Métabolisme , Substance P , Métabolisme , Thiourée , Utilisations thérapeutiquesRÉSUMÉ
<p><b>OBJECTIVE</b>To investigate the effects of histamine on the neurotoxicity induced by beta-amyloid(1-42)(Abeta42) in rat phaeochromocytoma (PC12) cells.</p><p><b>METHODS</b>The in vitro model of Alzheimer's disease was constructed with A beta42-treated PC12 cells. Cell morphology and MTT assay were used to evaluate the cell toxicity and histamine effects. The different histamine antagonists were applied to investigate the involvement of receptor subtypes.</p><p><b>RESULT</b>The neurotoxicity was induced by A beta42 in a concentration-dependent manner, which was reversed by histamine at concentration of 10(-7), 10(-6) mol/L. The effect was reversed by H(2) antagonist zolantidine and H(3)antagonist clobenpropit, but not by H(1) antagonist diphenhydramine.</p><p><b>CONCLUSION</b>Histamine reduces neurotoxicity induced by beta-amyloid(1-42), which may be mediated by H(2) and H(3)receptors.</p>
Sujet(s)
Animaux , Rats , Maladie d'Alzheimer , Métabolisme , Peptides bêta-amyloïdes , Toxicité , Benzothiazoles , Pharmacologie , Diphénhydramine , Pharmacologie , Relation dose-effet des médicaments , Histamine , Pharmacologie , Antihistaminiques des récepteurs H2 , Pharmacologie , Antihistaminiques des récepteurs H3 , Pharmacologie , Imidazoles , Pharmacologie , Neuroprotecteurs , Métabolisme , Pharmacologie , Cellules PC12 , Phénoxypropanolamines , Pharmacologie , Pipéridines , Pharmacologie , Récepteur histaminergique H2 , Métabolisme , Récepteur histaminergique H3 , Métabolisme , Thiourée , PharmacologieRÉSUMÉ
<p><b>AIM</b>To investigate the effect of selective H3 receptor agonist(R)-alpha-methylhistamine and antagonist thioperamide on the respiratory response in asthmatic guinea pigs respectively.</p><p><b>METHODS</b>Anesthesized guinea pigs were prepared with a implanted intracerebroventricular (icv) cannula and instrumented for the measurement of respiratory rate (RR) and diaphragmatic electric activity (DA). Substance P-like immunoreactive (SP-LI) substances in lower respiratory tract were detected by immunohistochemical method. Brain histamine contents were measured by fluorometric determination.</p><p><b>RESULTS</b>(1) Intravenous injection of ovalbumin caused tachypnea and significant decrease in DA magnitude. At the same time, SP-LI substances increased in trachea, bronchus and lung. (2) Administration of selective H3 receptor agonist (R)-alpha-methylhistamine (5 microg) icv immediately after i.v. ovalbumin could significantly ameliorate the changes in RR and DA induced by ovalbumin. In accordance, SP-LI substances in lower respiratory tract markedly decreased at 5 min and 10 min after (R)-alpha-methylhistamine microinjection. (3) Icv thioperamide (20 microg) caused a significant increase in RR and a decrease in DA. (4) Brain histamine contents increased in hypothalamus and cortex during asthma. After microinjection of thioperamide (20 microg) icv significant increase of histamine contents in hypothalamus and cortex was observed.</p><p><b>CONCLUSION</b>Brain histamine H3 receptors may be related to asthmatic respiratory responses.</p>